Annual Accounts Receivable
$131.23 M
+$11.52 M+9.62%
December 31, 2023
Summary
- As of February 7, 2025, NEO annual accounts receivable is $131.23 million, with the most recent change of +$11.52 million (+9.62%) on December 31, 2023.
- During the last 3 years, NEO annual accounts receivable has risen by +$24.38 million (+22.82%).
- NEO annual accounts receivable is now at all-time high.
Performance
NEO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$151.43 M
+$4.85 M+3.31%
September 30, 2024
Summary
- As of February 7, 2025, NEO quarterly accounts receivable is $151.43 million, with the most recent change of +$4.85 million (+3.31%) on September 30, 2024.
- Over the past year, NEO quarterly accounts receivable has increased by +$20.20 million (+15.39%).
- NEO quarterly accounts receivable is now at all-time high.
Performance
NEO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NEO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.6% | +15.4% |
| 3 y3 years | +22.8% | +44.3% |
| 5 y5 years | +70.6% | +66.2% |
NEO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.0% | at high | +36.7% |
| 5 y | 5-year | at high | +39.2% | at high | +72.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
NeoGenomics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $151.43 M(+3.3%) |
| Jun 2024 | - | $146.58 M(+4.5%) |
| Mar 2024 | - | $140.28 M(+6.9%) |
| Dec 2023 | $131.23 M(+9.6%) | $131.23 M(-1.1%) |
| Sep 2023 | - | $132.64 M(+5.8%) |
| Jun 2023 | - | $125.42 M(+5.5%) |
| Mar 2023 | - | $118.84 M(-0.7%) |
| Dec 2022 | $119.71 M(+6.8%) | $119.71 M(+6.9%) |
| Sep 2022 | - | $111.99 M(+0.6%) |
| Jun 2022 | - | $111.28 M(+0.4%) |
| Mar 2022 | - | $110.80 M(-1.2%) |
| Dec 2021 | $112.13 M(+4.9%) | $112.13 M(+6.8%) |
| Sep 2021 | - | $104.96 M(-1.2%) |
| Jun 2021 | - | $106.28 M(+3.3%) |
| Mar 2021 | - | $102.92 M(-3.7%) |
| Dec 2020 | $106.84 M(+13.4%) | $106.84 M(+3.0%) |
| Sep 2020 | - | $103.70 M(+18.2%) |
| Jun 2020 | - | $87.77 M(-12.2%) |
| Mar 2020 | - | $99.97 M(+6.1%) |
| Dec 2019 | $94.24 M(+22.5%) | $94.24 M(+3.4%) |
| Sep 2019 | - | $91.13 M(+1.3%) |
| Jun 2019 | - | $89.99 M(+9.0%) |
| Mar 2019 | - | $82.58 M(+7.4%) |
| Dec 2018 | $76.92 M(+27.3%) | $76.92 M(+22.7%) |
| Sep 2018 | - | $62.69 M(+3.2%) |
| Jun 2018 | - | $60.77 M(+4.5%) |
| Mar 2018 | - | $58.13 M(-3.8%) |
| Dec 2017 | $60.43 M(+8.9%) | $60.43 M(-3.7%) |
| Sep 2017 | - | $62.72 M(+1.6%) |
| Jun 2017 | - | $61.75 M(+0.1%) |
| Mar 2017 | - | $61.72 M(+11.2%) |
| Dec 2016 | $55.51 M(+13.4%) | $55.51 M(+10.6%) |
| Sep 2016 | - | $50.18 M(-6.2%) |
| Jun 2016 | - | $53.51 M(+6.8%) |
| Mar 2016 | - | $50.09 M(+2.3%) |
| Dec 2015 | $48.94 M(+139.0%) | $48.94 M(+127.1%) |
| Sep 2015 | - | $21.56 M(+2.0%) |
| Jun 2015 | - | $21.13 M(-1.6%) |
| Mar 2015 | - | $21.48 M(+4.9%) |
| Dec 2014 | $20.48 M(+9.8%) | $20.48 M(+11.9%) |
| Sep 2014 | - | $18.30 M(-2.7%) |
| Jun 2014 | - | $18.80 M(-2.4%) |
| Mar 2014 | - | $19.26 M(+3.3%) |
| Dec 2013 | $18.65 M | $18.65 M(+18.6%) |
| Sep 2013 | - | $15.73 M(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $16.00 M(+2.4%) |
| Mar 2013 | - | $15.63 M(+11.4%) |
| Dec 2012 | $14.03 M(+77.8%) | $14.03 M(+16.8%) |
| Sep 2012 | - | $12.01 M(+6.1%) |
| Jun 2012 | - | $11.33 M(+6.0%) |
| Mar 2012 | - | $10.68 M(+35.3%) |
| Dec 2011 | $7.89 M(+50.8%) | $7.89 M(+7.2%) |
| Sep 2011 | - | $7.37 M(+2.9%) |
| Jun 2011 | - | $7.16 M(+15.6%) |
| Mar 2011 | - | $6.19 M(+18.2%) |
| Dec 2010 | $5.24 M(+13.0%) | $5.24 M(-7.0%) |
| Sep 2010 | - | $5.63 M(+4.5%) |
| Jun 2010 | - | $5.38 M(-1.9%) |
| Mar 2010 | - | $5.49 M(+18.6%) |
| Dec 2009 | $4.63 M(+59.0%) | $4.63 M(+11.0%) |
| Sep 2009 | - | $4.17 M(+0.1%) |
| Jun 2009 | - | $4.17 M(+5.5%) |
| Mar 2009 | - | $3.96 M(+35.8%) |
| Dec 2008 | $2.91 M(-10.0%) | $2.91 M(-13.8%) |
| Sep 2008 | - | $3.38 M(-7.2%) |
| Jun 2008 | - | $3.64 M(+24.0%) |
| Mar 2008 | - | $2.94 M(-9.2%) |
| Dec 2007 | $3.24 M(+108.9%) | $3.24 M(+15.2%) |
| Sep 2007 | - | $2.81 M(+23.6%) |
| Jun 2007 | - | $2.27 M(+14.4%) |
| Mar 2007 | - | $1.99 M(+28.2%) |
| Dec 2006 | $1.55 M(+181.2%) | $1.55 M(+36.4%) |
| Sep 2006 | - | $1.14 M(+10.0%) |
| Jun 2006 | - | $1.03 M(+15.0%) |
| Mar 2006 | - | $898.10 K(+63.0%) |
| Dec 2005 | $551.10 K(+875.4%) | $551.10 K(+47.3%) |
| Sep 2005 | - | $374.10 K(+34.4%) |
| Jun 2005 | - | $278.40 K(+96.6%) |
| Mar 2005 | - | $141.60 K(+150.6%) |
| Dec 2004 | $56.50 K(-11.6%) | $56.50 K(-14.8%) |
| Sep 2004 | - | $66.30 K(+31.8%) |
| Jun 2004 | - | $50.30 K(-26.1%) |
| Mar 2004 | - | $68.10 K(+6.6%) |
| Dec 2003 | $63.90 K(+59.4%) | $63.90 K(+30.7%) |
| Sep 2003 | - | $48.90 K(-28.6%) |
| Jun 2003 | - | $68.50 K(-6.8%) |
| Mar 2003 | - | $73.50 K(+83.3%) |
| Dec 2002 | $40.10 K | $40.10 K(+29.8%) |
| Sep 2002 | - | $30.90 K(+306.6%) |
| Jun 2002 | - | $7600.00(+145.2%) |
| Jun 2000 | - | $3100.00 |
FAQ
- What is NeoGenomics annual accounts receivable?
- What is the all time high annual accounts receivable for NeoGenomics?
- What is NeoGenomics annual accounts receivable year-on-year change?
- What is NeoGenomics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for NeoGenomics?
- What is NeoGenomics quarterly accounts receivable year-on-year change?
What is NeoGenomics annual accounts receivable?
The current annual accounts receivable of NEO is $131.23 M
What is the all time high annual accounts receivable for NeoGenomics?
NeoGenomics all-time high annual accounts receivable is $131.23 M
What is NeoGenomics annual accounts receivable year-on-year change?
Over the past year, NEO annual accounts receivable has changed by +$11.52 M (+9.62%)
What is NeoGenomics quarterly accounts receivable?
The current quarterly accounts receivable of NEO is $151.43 M
What is the all time high quarterly accounts receivable for NeoGenomics?
NeoGenomics all-time high quarterly accounts receivable is $151.43 M
What is NeoGenomics quarterly accounts receivable year-on-year change?
Over the past year, NEO quarterly accounts receivable has changed by +$20.20 M (+15.39%)